Series C funding is the third major round of institutional investment a company raises, and it typically marks the point where a proven business is preparing for a public offering or a major acquisition. By this stage the product works, the revenue is real, and the money is aimed at winning a market rather than testing whether one exists. The average Series C round on Carta hit roughly $58 million in early 2024, though individual rounds regularly exceed $100 million depending on the sector and growth trajectory.
What Series C Money Is Used For
Companies raising a Series C already know their model works. The capital funds the push to dominate a market before competitors close the gap. In practice that means some combination of international expansion, strategic acquisitions, and the operational spending required to double or triple headcount across engineering, sales, and operations.
Buying smaller competitors is one of the most common uses. An acquisition eliminates a rival and folds in new technology or customers faster than building from scratch, and companies at this scale can capture cost efficiencies that were not available when they were smaller. Every dollar is oriented toward maximizing enterprise value ahead of a liquidity event, whether an IPO or a sale.
Series C rounds also increasingly include a secondary component, where founders or early employees sell a small portion of their shares to incoming investors. Selling roughly 5% to 10% of a founder’s holdings is generally considered reasonable when paired with strong business performance. That gives founders meaningful personal liquidity years before an IPO without requiring them to leave.
Who Invests at the Series C Stage
The investor mix shifts from earlier rounds. Late-stage venture capital firms and private equity groups anchor most Series C rounds, and hedge funds and investment banks frequently participate because a public exit is visible from here. These investors accept lower upside in exchange for lower risk. The company has revenue, market share, and institutional credibility a seed-stage startup cannot offer.
Check sizes reflect that confidence. The average Series C round on Carta in Q1 2024 was approximately $58.2 million, the highest since Q1 2022, with some individual rounds topping $100 million. The median has continued climbing since, approaching $80 million by early 2025.
A distinctive feature is the arrival of crossover investors, public market funds that invest in late-stage private companies roughly six to eighteen months before an anticipated IPO. Their participation validates the valuation using public-company comparable metrics and builds relationships with institutional investors who are likely to buy into the eventual IPO.
What Investors Require Before Funding
Series C investors are not betting on potential. They want proof, and the diligence process reflects that.
Audited financial statements are the starting point. Investors expect clean books prepared under Generally Accepted Accounting Principles, covering at least two to three years of operating history. They want audited historical performance that supports realistic projections, not a hockey stick forecast built on optimism. A company that cannot show a clear path to profitability, or that is not already profitable and growing, will struggle to attract this caliber of capital.
Beyond the financials, the company maintains a virtual data room holding everything the investor’s legal and financial teams will examine: tax records, intellectual property filings, key employment agreements, customer contracts, and a detailed capitalization table showing every share outstanding. The cap table needs to be clean. No unresolved ownership disputes, no lingering liens, no convertible instruments with unclear terms. Messy equity structures kill deals at this level because the investors pricing the round need certainty about what they are buying.
Valuation is typically anchored to revenue multiples. Depending on the industry, companies are commonly valued at five to ten times annual recurring revenue, with the exact multiple driven by growth rate, margin profile, and competitive position.
How the Round Closes
The closing process runs more legal machinery than earlier rounds, and the timeline from term sheet to wire transfer typically takes two to four months.
The deal begins with a non-binding term sheet outlining valuation, investment amount, and key investor rights. Once signed, formal due diligence begins, generally taking two to four weeks. Third-party specialists dig into the financials, and technology companies also face a separate technical review of the product architecture and engineering team.
After diligence clears, lawyers draft the definitive investment agreements, including the terms of the new class of preferred stock. Because a new class of shares is being created, the company must file an amended certificate of incorporation with its state of incorporation, typically Delaware, to formally authorize the new stock before any funds change hands. Funds then transfer electronically, and the company updates its capitalization table to reflect the new ownership and the diluted positions of existing shareholders.
One federal filing sits on a hard deadline. Because Series C shares are sold without public registration, the offering must qualify for an exemption under Regulation D, most commonly Rule 506(b), which limits the offering to accredited investors and up to 35 sophisticated non-accredited purchasers, or Rule 506(c), which allows general solicitation but requires all purchasers to be accredited investors whose status has been independently verified. Under either exemption, the company must file a Form D notice with the SEC through EDGAR within 15 calendar days after the first sale of securities. If the deadline falls on a weekend or holiday, it shifts to the next business day. There is no filing fee, and paper filings are not accepted. Missing the 15-day window does not automatically void the exemption, but the company should file as soon as practicable and may face other consequences under Rule 507.
The Deal Terms That Matter Most
The financial terms negotiated in a Series C round directly affect how much money each shareholder walks away with when the company is eventually sold or goes public. A few provisions dominate the term sheet.
Liquidation Preferences
A liquidation preference determines who gets paid first, and how much, when the company is sold or dissolved. The standard in most venture rounds is a 1x non-participating preference: investors get back exactly what they put in before common shareholders see a dollar, and then they convert to common stock to share in the remaining proceeds. In later-stage rounds, structured terms appear more often. About 8% of all new funding rounds on Carta in Q1 2024 included liquidation preferences of 1x or higher, the highest rate in a decade, and participating preferred structures with caps between 1.5x and 3x are becoming more visible in Series B and C deals. Participating preferred is the more aggressive version, letting investors recover their full investment and then take a proportional cut of what remains.
Protective Provisions
Series C investors almost always negotiate protective provisions, which are corporate actions the company cannot take without preferred stockholders’ approval. Typical items include selling or merging the company, issuing new stock that ranks senior to the Series C, amending the corporate charter, taking on debt above a specified threshold, and modifying the employee equity plan. Voting thresholds vary, but approval from at least 60% of a given series of preferred stock is a common structure.
Anti-Dilution Protection
Every Series C term sheet addresses what happens if the company’s next round prices lower than the current one, known as a down round. Anti-dilution provisions adjust the conversion price of Series C preferred into common stock, effectively giving investors more shares to compensate for the loss in value. Broad-based weighted average is the market norm, adjusting the conversion price proportionally based on how many new shares are issued and at what price. The alternative, full ratchet, reprices the preferred entirely to the lower round’s price regardless of how many shares are issued, which is a much harsher outcome for founders and employees holding common stock.
How Series C Affects Founder and Employee Equity
Dilution is the unavoidable cost of raising venture capital, and by Series C the cumulative effect is significant. A typical Series C round dilutes existing shareholders by 10% to 15%, depending on the amount raised and the pre-money valuation. Founders who raised seed, Series A, and Series B rounds have already given up substantial ownership along the way. A founder who started with 100% and experienced typical dilution at each stage might hold 30% to 40% of the company by the time Series C closes.
Employee equity also takes a hit. Companies at this stage frequently refresh their option pool to retain key talent and attract senior hires ahead of an IPO. The size of that refresh is negotiated as part of the Series C term sheet, and investors typically insist that any increase to the pool come out of the pre-money valuation, meaning existing shareholders absorb the dilution rather than the new investors.
QSBS Tax Eligibility Can Break at Series C
Section 1202 of the Internal Revenue Code offers a powerful benefit for shareholders of qualifying small businesses: a 100% exclusion on capital gains from the sale of qualified small business stock (QSBS), up to the greater of $10 million or ten times the shareholder’s adjusted basis in the stock. For founders and early employees, this can eliminate federal capital gains tax on millions of dollars of profit.
The catch is that the company must qualify as a “qualified small business” at the time the stock is issued, and the key test is a gross asset ceiling. For stock acquired after July 4, 2025, the company’s aggregate gross assets, meaning cash plus the adjusted basis of all other property, cannot exceed $75 million either before or immediately after the stock issuance. That threshold is indexed for inflation beginning after 2026. A large Series C round can easily push a company past the limit, because the capital raised counts toward the asset test immediately after issuance.
Stock issued during earlier rounds, when the company’s assets were below the threshold, remains eligible even if the company later grows past $75 million. But new stock issued as part of a Series C that pushes total assets over the line does not qualify. Anyone receiving new grants at the Series C stage should understand they may not benefit from the exclusion.
Board Seats and Governance
Series C investors expect a seat at the table, and the governance structure changes to reflect that. Board expansion is standard. Lead investors typically negotiate one or more board seats, and existing investors may push for additional representation. The board shifts from founder-dominated to one where institutional investors hold meaningful voting power.
Investors at this stage frequently push for independent directors with public-company experience, particularly if an IPO is on the horizon. They may also negotiate performance milestones tied to executive compensation and formal committee structures for audit, compensation, and nominating functions that mirror what public companies maintain. This overhead slows decision-making, but it builds the operational discipline public markets will demand.
Founder influence narrows. A founder who once made unilateral decisions now needs board approval for anything material. Negotiating board composition during the term sheet phase, rather than treating it as an afterthought, is one of the highest-leverage moves a founder can make at this stage.
What Typically Follows Series C
Most companies that close a Series C are within a few years of a liquidity event. The three common paths are an IPO, acquisition by a larger company, or additional private rounds (Series D or E) to bridge the gap if the company needs more time or capital before going public.
A fourth possibility is less pleasant. If market conditions deteriorate or the company underperforms, the next financing may price below the Series C valuation. When that happens, the anti-dilution provisions negotiated at Series C activate, adjusting preferred stockholders’ conversion ratios at the expense of common holders. Founders and employees holding common stock absorb the worst of it, which is why the choice between weighted average and full ratchet anti-dilution matters so much when the term sheet is drafted.